<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-903-SPI-28405</iati-identifier>
  <reporting-org ref="XM-DAC-903" type="40">
   <narrative xml:lang="EN">International Finance Corporation</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Al Hikma V Project</narrative>
  </title>
  <description type="2">
   <narrative xml:lang="EN">-	 The investment will support south to south expansion.
- Hikma will have a demonstration effect increasing the number of FDA approved manufacturing facilities in the MENA region.
- Hikma will increase the availability of a wide range of quality medicines in the MENA region.
-	 The regional expansion will increase generic competition and increase access to affordable medicines.</narrative>
  </description>
  <description type="1">
   <narrative xml:lang="EN">Hikma Pharmaceuticals PLC (Hikma, the Company) and its subsidiaries (the Group) is a leading pharmaceutical producer in the Middle East North Africa (MENA) region, with operations and sales in four continents.  Hikma has grown from its base in Jordan both organically and through acquisitions, achieving important milestones, such as becoming the first Arab company to obtain a United States Food and Drug Administration (US FDA) approval in 1996, and listing on the London Stock Exchange in 2005.  The Company has invited IFC to support its 2010-2011 investment plan of approximately $300 million predominantly in the MENA region including the financing of acquisition opportunities and capital expansion in its existing facilities (the Project).</narrative>
  </description>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">HIKMA PHARMACEUTICALS LLC</narrative>
  </participating-org>
  <participating-org activity-id="XM-DAC-903-SPI-28405" ref="XM-DAC-903" role="1" type="40"></participating-org>
  <activity-status code="3"></activity-status>
  <activity-date iso-date="2011-12-19" type="1"></activity-date>
  <activity-date iso-date="2012-05-24" type="2"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">International Finance Corporation</narrative>
   </organisation>
   <telephone>+12024733800</telephone>
   <email>ccspg@ifc.org</email>
   <website>www.ifc.org</website>
   <mailing-address>
    <narrative xml:lang="EN">2121 Pennsylvania Avenue, NW Washington DC 20433</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN">Susan Ringdal
Investor Relations Director
Hikma Pharmaceuticals PLC13 Hanover SquareLondonW1S 1HLTel: +44 (0) 20 7399 2760
Fax: +44 (0) 20 7399 2761

Bashar Shomali
Group Treasurer
Hikma Pharmaceuticals Lts. Co.
P.O. Box 182400 Amman
11118 Jordan
Tel: + 96265802900
Fax: + 96265817102</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN"></narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="JO" percentage="100">
   <narrative xml:lang="EN">Jordan</narrative>
  </recipient-country>
  <location ref="JO-Jordan">
   <location-reach code="1"></location-reach>
   <location-id code="1453782" vocabulary="G1"></location-id>
   <name>
    <narrative xml:lang="EN">Hikmas investment plan will involve acquisitions in the MENA region and other emerging markets, along with capital expenditures for its facilities in MENA.</narrative>
   </name>
   <description>
    <narrative xml:lang="EN">Location description</narrative>
   </description>
   <activity-description>
    <narrative xml:lang="EN">A description that qualifies the activity taking place at the location.</narrative>
   </activity-description>
   <administrative code="1453782" level="1" vocabulary="G1"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>31.0000000000 36.0000000000</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="1"></location-class>
   <feature-designation code="ADMF"></feature-designation>
  </location>
  <sector percentage="100" vocabulary="11" vocabulary-uri="http://www.census.gov/cgi-bin/sssd/naics/naicsrch?chart=2012">
   <narrative xml:lang="EN">FA - Pharmaceuticals and Medicine</narrative>
  </sector>
  <country-budget-items vocabulary="1">
   <budget-item code="7.2.1" percentage="100" vocabulary="1">
    <description>
     <narrative xml:lang="EN">Total: $137.50 million</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="6"></collaboration-type>
  <default-flow-type code="35"></default-flow-type>
  <default-finance-type code="411"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget type="1">
   <period-start iso-date="2011-12-19"></period-start>
   <period-end iso-date="2012-06-30"></period-end>
   <value currency="USD" value-date="2011-12-19">110000000</value>
  </budget>
  <budget type="1">
   <period-start iso-date="2011-12-19"></period-start>
   <period-end iso-date="2012-06-30"></period-end>
   <value currency="USD" value-date="2011-12-19">27500000</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2011-12-19"></transaction-date>
   <value currency="USD" value-date="2011-12-19">110000000</value>
   <receiver-org>
    <narrative xml:lang="EN">HIKMA PHARMACEUTICALS LLC</narrative>
   </receiver-org>
   <flow-type code="35"></flow-type>
   <finance-type code="411"></finance-type>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2011-12-19"></transaction-date>
   <value currency="USD" value-date="2011-12-19">27500000</value>
   <receiver-org>
    <narrative xml:lang="EN">HIKMA PHARMACEUTICALS LLC</narrative>
   </receiver-org>
   <flow-type code="35"></flow-type>
   <finance-type code="510"></finance-type>
  </transaction>
  <document-link format="TEXT/HTML" url="https://disclosures.ifc.org/project-detail/SPI/28405/al-hikma-v-project">
   <title>
    <narrative xml:lang="EN">Summary of Project Information</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
 </iati-activity>
</iati-activities>
